Cargando…
Cytochrome P450 2A6 whole-gene deletion (CYP2A6*4) polymorphism reduces risk of lung cancer: A meta-analysis
INTRODUCTION: Lung cancer is the most commonly diagnosed cancer worldwide and is the leading cause of cancer death. Smoking is a major contributor to the pathogenesis of lung cancer. Cytochrome P450 2A6 (CYP2A6) is responsible for the metabolic activation of most tobacco carcinogens. CYP2A6 genetic...
Autores principales: | Johani, Fadzrul H., Majid, Mohd S. A., Azme, Muhammad H., Nawi, Azmawati M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID)
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291960/ https://www.ncbi.nlm.nih.gov/pubmed/32547353 http://dx.doi.org/10.18332/tid/122465 |
Ejemplares similares
-
Dataset for genotyping validation of cytochrome P450 2A6 whole-gene deletion (CYP2A6*4) by real-time polymerase chain reaction platforms
por: Shimizu, Makiko, et al.
Publicado: (2015) -
Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance
por: Zanger, Ulrich M., et al.
Publicado: (2013) -
A longitudinal study of cytochrome P450 2D6 (CYP2D6) activity during adolescence
por: Leeder, J. Steven, et al.
Publicado: (2022) -
Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer
por: Bezerra, Lucas Soares, et al.
Publicado: (2018) -
Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation
por: El-Serafi, Ibrahim, et al.
Publicado: (2015)